UK Medicines and Healthcare Products Regulatory Agency (MHRA), the country’s main medical regulator, gave a $1.96 million contract to the U.K. arm of Genpact, the U.S.- listed business process outsourcing firm, to build an artificial intelligence (AI) software to spot any potential safety concerns with its planned mass vaccination program for COVID-19.
News reports revealed that the government is expected to approve one or more coronavirus vaccines before the end of the year. MHRA was told to prepare for a mass vaccination campaign “by Christmas.”
However, the MHRA told the Financial Times that based on its previous experience with vaccination campaigns, they’re expecting that over a six- to 12-month period, there might be 50,000 to 100,000 reports of suspicious side effects for every 100 million doses injected. MHRA will then need the help of Genpact to automate this process.